-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
New clues about how the brain chemical transmitter GABA functions suggest that a protein "anchoring" plays a key role
in helping its receptors localize in nerve cells.
A new study published in the journal Nature Communications has found that a protein called serine protein a is responsible for directing receptors to the right place
in brain cells.
These receptors control the brain's response to GABA, the main inhibitory neurotransmitter
in the brain.
GABA plays a vital role in the brain, including controlling body movement and pain transmission
.
By activating specific receptors in the brain, GABA maintains proper brain activity
by slowing down the electrical impulses that travel between brain cells.
The researchers found that serine protein A is involved in localizing these receptors, which could allow researchers to develop new therapies to treat a range of neurological disorders
, including multiple sclerosis.
Davide Calebiro, professor of molecular endocrinology at the University of Birmingham and lead author of the paper, said:
"Serine protein A answers a question scientists have been asking about how GABA controls a range of functions
in the brain.
By pinpointing GABA-b receptors like anchors, it allows GABA to regulate a full range of brain functions
involved in a variety of neurological disorders.
While GABA-a receptors have received much of the attention for mediating rapid GABA responses, twin B who mediates slower responses is a huge potential drug target, and our findings could have significant implications for
treating a variety of conditions, from multiple sclerosis to epilepsy.
"
Furthermore, we hypothesize that a defect in serine protein A may impair the normal localization of GABA-B receptors in neurons, disrupting the proper processing of signals in the brain, ultimately leading to the inability of the brain to communicate
effectively with the rest of the body.
”
The Membrane Proteins and Receptors Centre (COMPARE), a research institute at the University of Birmingham in collaboration with the University of Nottingham, has developed a new pioneering research method to discover the role of
serine protein A in GABA activity.
In particular, the use of single-molecule and super-resolution microscopy methods developed by Calebiro's lab allowed the research team to directly track the interactions
of individual receptors and silk protein molecules on the surface of living cells in unprecedented detail.
Filamin A organizes γ?aminobutyric acid type B receptors at the plasma membrane